These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

652 related items for PubMed ID: 17440111

  • 1. Estrogen receptor beta2 negatively regulates the transactivation of estrogen receptor alpha in human breast cancer cells.
    Zhao C, Matthews J, Tujague M, Wan J, Ström A, Toresson G, Lam EW, Cheng G, Gustafsson JA, Dahlman-Wright K.
    Cancer Res; 2007 Apr 15; 67(8):3955-62. PubMed ID: 17440111
    [Abstract] [Full Text] [Related]

  • 2. Selenium disrupts estrogen signaling by altering estrogen receptor expression and ligand binding in human breast cancer cells.
    Lee SO, Nadiminty N, Wu XX, Lou W, Dong Y, Ip C, Onate SA, Gao AC.
    Cancer Res; 2005 Apr 15; 65(8):3487-92. PubMed ID: 15833885
    [Abstract] [Full Text] [Related]

  • 3. Estrogen receptor alpha and beta subtype expression and transactivation capacity are differentially affected by receptor-, hsp90- and immunophilin-ligands in human breast cancer cells.
    Gougelet A, Bouclier C, Marsaud V, Maillard S, Mueller SO, Korach KS, Renoir JM.
    J Steroid Biochem Mol Biol; 2005 Feb 15; 94(1-3):71-81. PubMed ID: 15862952
    [Abstract] [Full Text] [Related]

  • 4. Inducible upregulation of oestrogen receptor-beta1 affects oestrogen and tamoxifen responsiveness in MCF7 human breast cancer cells.
    Murphy LC, Peng B, Lewis A, Davie JR, Leygue E, Kemp A, Ung K, Vendetti M, Shiu R.
    J Mol Endocrinol; 2005 Apr 15; 34(2):553-66. PubMed ID: 15821116
    [Abstract] [Full Text] [Related]

  • 5. TFAP2C controls hormone response in breast cancer cells through multiple pathways of estrogen signaling.
    Woodfield GW, Horan AD, Chen Y, Weigel RJ.
    Cancer Res; 2007 Sep 15; 67(18):8439-43. PubMed ID: 17875680
    [Abstract] [Full Text] [Related]

  • 6. Potential of endogenous estrogen receptor beta to influence the selective ER modulator ERbeta complex.
    Chen B, Gajdos C, Dardes R, Kidwai N, Johnston SR, Dowsett M, Jordan VC.
    Int J Oncol; 2005 Aug 15; 27(2):327-35. PubMed ID: 16010412
    [Abstract] [Full Text] [Related]

  • 7. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C, Nichol JN, Pettersson F, Couture MC, Miller WH.
    Mol Cancer Res; 2004 Sep 15; 2(9):523-31. PubMed ID: 15383631
    [Abstract] [Full Text] [Related]

  • 8. Menin, a product of the MENI gene, binds to estrogen receptor to enhance its activity in breast cancer cells: possibility of a novel predictive factor for tamoxifen resistance.
    Imachi H, Murao K, Dobashi H, Bhuyan MM, Cao X, Kontani K, Niki S, Murazawa C, Nakajima H, Kohno N, Yamashita H, Iwase H, Hayashi S, Ishida T, Yamauchi A.
    Breast Cancer Res Treat; 2010 Jul 15; 122(2):395-407. PubMed ID: 19847644
    [Abstract] [Full Text] [Related]

  • 9. Activation of mitogen-activated protein kinase in estrogen receptor alpha-positive breast cancer cells in vitro induces an in vivo molecular phenotype of estrogen receptor alpha-negative human breast tumors.
    Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D.
    Cancer Res; 2006 Apr 01; 66(7):3903-11. PubMed ID: 16585219
    [Abstract] [Full Text] [Related]

  • 10. Binding of estrogen receptor alpha/beta heterodimers to chromatin in MCF-7 cells.
    Papoutsi Z, Zhao C, Putnik M, Gustafsson JA, Dahlman-Wright K.
    J Mol Endocrinol; 2009 Aug 01; 43(2):65-72. PubMed ID: 19376833
    [Abstract] [Full Text] [Related]

  • 11. Ganoderma lucidum inhibits proliferation of human breast cancer cells by down-regulation of estrogen receptor and NF-kappaB signaling.
    Jiang J, Slivova V, Sliva D.
    Int J Oncol; 2006 Sep 01; 29(3):695-703. PubMed ID: 16865287
    [Abstract] [Full Text] [Related]

  • 12. The WT1 Wilms' tumor suppressor gene product interacts with estrogen receptor-alpha and regulates IGF-I receptor gene transcription in breast cancer cells.
    Reizner N, Maor S, Sarfstein R, Abramovitch S, Welshons WV, Curran EM, Lee AV, Werner H.
    J Mol Endocrinol; 2005 Aug 01; 35(1):135-44. PubMed ID: 16087727
    [Abstract] [Full Text] [Related]

  • 13. Estrogen receptor (ER) beta1 and ERbetacx/beta2 inhibit ERalpha function differently in breast cancer cell line MCF7.
    Omoto Y, Eguchi H, Yamamoto-Yamaguchi Y, Hayashi S.
    Oncogene; 2003 Aug 07; 22(32):5011-20. PubMed ID: 12902984
    [Abstract] [Full Text] [Related]

  • 14. Estrogen receptor beta exerts growth-inhibitory effects on human mammary epithelial cells.
    Treeck O, Lattrich C, Springwald A, Ortmann O.
    Breast Cancer Res Treat; 2010 Apr 07; 120(3):557-65. PubMed ID: 19434490
    [Abstract] [Full Text] [Related]

  • 15. Expression of estrogen receptor beta increases integrin alpha1 and integrin beta1 levels and enhances adhesion of breast cancer cells.
    Lindberg K, Ström A, Lock JG, Gustafsson JA, Haldosén LA, Helguero LA.
    J Cell Physiol; 2010 Jan 07; 222(1):156-67. PubMed ID: 19780039
    [Abstract] [Full Text] [Related]

  • 16. The changes of estrogen receptor-beta variants expression in breast carcinogenesis: Decrease of estrogen receptor-beta2 expression is the key event in breast cancer development.
    Park BW, Kim KS, Heo MK, Yang WI, Kim SI, Kim JH, Kim GE, Lee KS.
    J Surg Oncol; 2006 May 01; 93(6):504-10. PubMed ID: 16615154
    [Abstract] [Full Text] [Related]

  • 17. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G, Hall JA, Perry MC, Laganière J, Ghahremani M, Park M, Hallett M, Giguère V.
    Cancer Res; 2009 Aug 01; 69(15):6149-57. PubMed ID: 19622763
    [Abstract] [Full Text] [Related]

  • 18. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z, Reierstad S, Huang CC, Bulun SE.
    Cancer Res; 2007 May 15; 67(10):5017-24. PubMed ID: 17510434
    [Abstract] [Full Text] [Related]

  • 19. Proteasome-independent down-regulation of estrogen receptor-alpha (ERalpha) in breast cancer cells treated with 4,4'-dihydroxy-trans-stilbene.
    Balan KV, Wang Y, Chen SW, Chen JC, Zheng LF, Yang L, Liu ZL, Pantazis P, Wyche JH, Han Z.
    Biochem Pharmacol; 2006 Aug 28; 72(5):573-81. PubMed ID: 16822479
    [Abstract] [Full Text] [Related]

  • 20. Estrogen receptor regulates insulin-like growth factor-I receptor gene expression in breast tumor cells: involvement of transcription factor Sp1.
    Maor S, Mayer D, Yarden RI, Lee AV, Sarfstein R, Werner H, Papa MZ.
    J Endocrinol; 2006 Dec 28; 191(3):605-12. PubMed ID: 17170218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.